Model cards, and the frameworks built around them like CHAI and BRIDGE, describe an AI model: its intended use, its data, its performance, and its limits. They are valuable for governance and procurement. But they are written before any specific inference, so they cannot prove what a model did on a specific input at a specific time. Documentation describes a system; proof shows what it actually did and lets a third party check. Treating a model card as if it settles what happened in a disputed case is a category error, and it is the error at the center of how healthcare talks about AI trust. The stakes are real: 81 percent of physicians use AI professionally and 76 percent believe it improves care,[1] so these tools are shaping decisions that get reviewed, and description is not the same as evidence.
This piece defines what model cards are, names the claim they cannot make, draws the line between documentation and proof, credits where transparency genuinely helps, and shows what provenance adds on top. RankShieldMD supplies that provenance layer and proves what a model did without rendering the decision. See how it works in clinical AI provenance and how the three pillars fit in governance, security, and provenance.
What model cards, CHAI, and BRIDGE actually are
They are transparency artifacts: structured documentation of what a model is, what it is for, and where it falls short.
The model card began as a way to standardize how a model is described: intended use, training and evaluation data, performance across subgroups, and known limitations, in a consistent format. Healthcare has embraced the idea. The Coalition for Health AI has promoted model cards as a transparency standard for clinical AI, and frameworks such as BRIDGE, developed with industry partners, extend structured documentation and governance guidance further. These efforts are worth taking seriously. A shared format lets a health system compare tools fairly, gives a governance committee a real checklist, and pressures vendors to disclose weaknesses they might otherwise soften. The FDA's own direction on clinical decision support leans on transparency and the ability of a clinician to independently review the basis of a recommendation.[3] All of this is genuine progress. It is also, in every case, documentation: a description of the model in general, produced before it processes any particular patient.
The claim they cannot make: what happened at inference
Because a model card is written before any specific inference, it cannot attest to what the model did on a specific input in a specific case.
This is not a flaw in model cards; it is their nature. A description of a tool, however thorough, is not a record of a specific use of that tool. When a clinical AI decision is questioned months later, the operative questions are concrete: did this output come from this model version, on these unaltered inputs, and did a clinician review it. A model card cannot answer any of them, because it existed before the event and says nothing about it. It can establish that the model is intended for the task and performed at a certain level in testing, which speaks to whether adopting it was reasonable. It cannot establish what occurred in the instance under dispute. Confusing these is consequential, because it leads organizations to believe they have accountability they do not have. They can show what the model is supposed to do. They cannot show what it did. That is the difference between having documentation and having evidence.
Keep your model cards. Add the proof they cannot provide.
Request early access →Documentation versus proof, in plain language
Documentation states what a system is meant to do; proof is verifiable evidence of what it actually did, that someone else can check.
Strip away the jargon and the distinction is simple. Documentation is a claim about intent and capability, authored by the people responsible for the system. Proof is evidence about a specific event, structured so that someone who does not trust the author can still verify it. A model card is documentation: useful, honest at its best, and unverifiable as to any particular decision. A tamper-evident provenance record is proof: it binds a model version, an input digest, an output, and a signer, sealed so alteration is detectable and ideally anchored externally so a third party can confirm it. The test that separates them is adversarial. Ask of any artifact: if someone disputed it in bad faith, could an independent reviewer still confirm it. A model card fails that test for a specific decision, not because it is dishonest, but because it was never about a specific decision. Provenance passes it, because that is exactly what it is for.
Where transparency documents help, and where they stop
Transparency supports governance, procurement, and evaluation; it stops at the boundary of per-decision evidence.
It is worth being precise and fair, because the point is not that documentation is weak, it is that it is finite. Model cards and frameworks do real work at the front of the lifecycle: choosing whether to adopt a tool, evaluating its fit and risk, disclosing limitations, and giving a governance committee something concrete to assess. Standardization efforts raise the floor for the whole field, which is good for patients and buyers alike. Where they stop is the running system. Once the model is in production making decisions that get reviewed, the documentation cannot follow it into any specific case. That boundary is not a failure to fix within documentation; it is a signal that a second kind of artifact is required. Recognizing the boundary is how a serious program avoids a false sense of coverage. You keep the transparency work, and you add what it structurally cannot include: evidence of the individual decisions.
Adding verifiable provenance on top of documentation
Provenance is the layer that makes a documented, governed model also provable, one decision at a time.
The resolution is not to choose between documentation and proof; it is to stack them. Keep the model cards and adopt the frameworks, because they do the front-of-lifecycle work well. Then add provenance so that the running system emits, for each consequential decision, a tamper-evident, PHI-free record binding the model version, the input digest, the output, and the verified signer, checkable by a third party. Now a reviewer has both: the description of what the model is meant to do, and the evidence of what it did. That is a genuinely stronger posture than either alone, and it aligns with where regulation is pointing, toward transparency plus the ability to independently review and reconstruct decisions.[3] RankShieldMD provides this provenance layer. It sits on top of your transparency work, never renders the clinical decision, and never claims to make you compliant. Documentation tells the reviewer what your AI is. Provenance proves what it did. Healthcare, of all fields, needs both.
